Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Return on Sales (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Return on Sales for 15 consecutive years, with 0.12% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales fell 12.0% to 0.12% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.13%, a 5.0% increase, with the full-year FY2025 number at 0.13%, up 5.0% from a year prior.
  • Return on Sales was 0.12% for Q4 2025 at Niagen Bioscience, down from 0.13% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.25% in Q4 2024 to a low of 0.51% in Q3 2021.
  • A 5-year average of 0.11% and a median of 0.06% in 2022 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: decreased -22bps in 2021, then soared 36bps in 2023.
  • Niagen Bioscience's Return on Sales stood at 0.3% in 2021, then surged by 77bps to 0.07% in 2022, then surged by 108bps to 0.01% in 2023, then surged by 4483bps to 0.25% in 2024, then plummeted by -50bps to 0.12% in 2025.
  • Per Business Quant, the three most recent readings for NAGE's Return on Sales are 0.12% (Q4 2025), 0.13% (Q3 2025), and 0.12% (Q2 2025).